Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Depreciation Expense (2016 - 2018)

Historic Depreciation Expense for Fortress Biotech (FBIO) over the last 3 years, with Q3 2018 value amounting to $548000.0.

  • Fortress Biotech's Depreciation Expense rose 17400.0% to $548000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.3 million, marking a year-over-year increase of 5479.12%. This contributed to the annual value of $700000.0 for FY2017, which is 7500.0% up from last year.
  • According to the latest figures from Q3 2018, Fortress Biotech's Depreciation Expense is $548000.0, which was up 17400.0% from $466000.0 recorded in Q2 2018.
  • In the past 5 years, Fortress Biotech's Depreciation Expense registered a high of $548000.0 during Q3 2018, and its lowest value of -$119000.0 during Q4 2017.
  • For the 3-year period, Fortress Biotech's Depreciation Expense averaged around $199636.4, with its median value being $180000.0 (2017).
  • The largest annual percentage gain for Fortress Biotech's Depreciation Expense in the last 5 years was 675000.0% (2017), contrasted with its biggest fall of 17437.5% (2017).
  • Quarter analysis of 3 years shows Fortress Biotech's Depreciation Expense stood at $160000.0 in 2016, then crashed by 174.38% to -$119000.0 in 2017, then skyrocketed by 560.5% to $548000.0 in 2018.
  • Its last three reported values are $548000.0 in Q3 2018, $466000.0 for Q2 2018, and $365000.0 during Q1 2018.